Inventor
VEENSTRA SIEM JACOB
CH20 patents
⚠️ This page may combine multiple inventors who share the name “VEENSTRA SIEM JACOB”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
11 patentsUS6117873ASep 12, 2000
Substituted aminoalkane phosphonic acids
NOVARTIS AG42 citations92
US6080743AJun 27, 2000
2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
NOVARTIS AG16 citations83
US5965562AOct 12, 1999
Aroyl-piperidine derivatives
NOVARTIS AG10 citations73
US5929067AJul 27, 1999
1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
NOVARTIS AG9 citations72
US10301296B2May 28, 2019
Heterocyclic derivatives and their use in the treatment of neurological disorders
NOVARTIS AG1 citations71
US10035794B2Jul 31, 2018
Heterocyclic derivatives and their use in the treatment of neurological disorders
NOVARTIS AG3 citations71
US7678814B2Mar 16, 2010
Aroyl-piperidine derivatives
NOVARTIS AG2 citations62
US7612055B2Nov 3, 2009
Macrocyclic lactams and pharmaceutical use thereof
NOVARTIS AG4 citations60
US10683287B2Jun 16, 2020
Heterocyclic derivatives and their use in the treatment of neurological disorders
NOVARTIS AG0 citations51
US8039455B2Oct 18, 2011
Macrocyclic compounds useful as BACE inhibitors
NOVARTIS AG0 citations39
US7612054B2Nov 3, 2009
Dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
NOVARTIS AG0 citations39
BADIGER SANGAMESH
3 patentsUS8637508B2Jan 28, 2014
Heterocyclic derivatives and their use in the treatment of neurological disorders
BADIGER SANGAMESH75 citations95
US9550758B2Jan 24, 2017
Heterocyclic derivatives and their use in the treatment of neurological disorders
BADIGER SANGAMESH4 citations82
US8865712B2Oct 21, 2014
Heterocyclic derivatives and their use in the treatment of neurological disorders
BADIGER SANGAMESH7 citations82